(Erstwhile SBI Pharma Fund) Table of Contents To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Healthcare Opportunities Fund is a Equity - Sectoral fund launched on 31 Dec 04. It is a fund with High risk and has given a Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on Historical performance (Yearly) on absolute basis SBI Healthcare Opportunities Fund - G
Scheme Objective
CAGR return of 13.9% since its launch. Ranked 34 in Sectoral category. Return for 2019 was -0.5% , 2018 was -9.9% and 2017 was 2.1% . NAV as on 7 Aug 20 ₹167.903 ↓ -0.40 (-0.24 %) Net Assets (AUM) as on 30 Jun 2020 ₹1,154 Cr. Launch Date 31 Dec 2004 Category Equity - Sectoral Rating ☆☆ Type Open Ended Fund Risk High AMC SBI Funds Management Private Limited Alpha Ratio 7.48 Expense Ratio 2.44 % Sharpe Ratio 1.129 Information Ratio -0.07 Benchmark Not Available Min Investment ₹5,000 Min SIP Investment ₹500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) NAV Price Chart
Returns
Annual Compounded Returns
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 7 Aug 20 Duration Returns 1 Month 16% 3 Month 22% 6 Month 30.7% 1 Year 55.1% 3 Year 10% 5 Year 2.9% 10 Year 15 Year Since launch 13.9% Historical Annual Returns
Year Returns 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% 2014 56.8% 2013 26% 2012 37.1% 2011 -5.5% Growth of 10k Over Years
Date Value 31 Jul 15 ₹10,000 31 Jul 16 ₹10,224 31 Jul 17 ₹8,929 31 Jul 18 ₹8,188 31 Jul 19 ₹7,601 31 Jul 20 ₹11,417 
Asset Allocation
Asset Class Value Cash 1.76% Equity 98.24% 
Sector Allocation
Sector Value Health Care 97.72% 
Top Securities Holdings / Portfolio
Holdings/Securities
Name Global Industry Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMADrug Manufacturers - Specialty & Generic 10% ₹118 Cr 2,500,000
↑ 100,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 500087Drug Manufacturers - General 10% ₹115 Cr 1,800,000 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMADrug Manufacturers - Specialty & Generic 9% ₹108 Cr 1,400,000
↑ 200,000 Lupin Ltd (Healthcare)
Equity, Since 31 Jul 18 | 500257Drug Manufacturers - Specialty & Generic 9% ₹105 Cr 1,150,000
↑ 150,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 20 | 500124Drug Manufacturers - Specialty & Generic 8% ₹87 Cr 220,000
↑ 45,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLABDrug Manufacturers - Specialty & Generic 7% ₹82 Cr 360,000 Alembic Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Aug 17 | 533573Drug Manufacturers - Specialty & Generic 5% ₹55 Cr 600,000 Abbott India Ltd (Healthcare)
Equity, Since 31 Mar 19 | 500488Drug Manufacturers - General 4% ₹47 Cr 30,000 Biocon Ltd (Healthcare)
Equity, Since 31 Jan 20 | 532523Biotechnology 4% ₹41 Cr 1,060,000
↑ 160,000 Strides Pharma Science Ltd (Healthcare)
Equity, Since 31 Mar 14 | STARDrug Manufacturers - Specialty & Generic 4% ₹41 Cr 1,000,000
Talk to our investment specialistFund Managers
Name Since Tenure Tanmaya Desai 1 Jun 11 9.09 Yr. Custodians
Company Address Bank of Nova Scotia 12/13, Maker Chamber VI,220, Nariman Point HDFC Bank Ltd HDFC Bank House,Kamala Mills Compound,Senapati Bapat Marg,,Lower Parel (W), SBI-SG Global Securities Services Private Limited “B Wing”, “Jeevan Seva” Annexe Bldg.,Ground Floor, S.V. Road,Santacruz (W),,Mumbai – 400054 Registrar & Transfer Agent
Computer Age Management Svcs Address New No.10, Old No.178,,Kodambakkam High Road,,Opp. Hotel Palmgrove,,Nungambakkam FAX 91-44-28283610 Email enq_L@camsonline.com Administrator Companies
Company Address SBI Mutual Fund 191"E", Maker Tower,Cuffe Parade Auditors
Company Address M/s. M. M. Nissim & Co. 3rdFloor, B Wing, Barodawala Mansion, 81,,Dr. Annie Besant Road, Worli, All Plan & Options
Fund and Plan NAV 6 Month 1 Year 3 Year 5 Year SBI Healthcare Opportunities Fund
Growth ₹167.903
↓ -0.40 30.66 % 55.09 % 9.96 % 2.94 % SBI Healthcare Opportunities Fund
Normal Dividend, Payout ₹105.77
↓ -0.25 30.67 % 55.1 % 9.97 % 2.95 % SBI Healthcare Opportunities Fund
Normal Dividend, Reinvestment ₹105.77
↓ -0.25 30.67 % 55.1 % 9.97 % 2.95 % Data as on 7 Aug 20
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data.
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2020 Shepard Technologies Private Limited. All Rights Reserved